세계의 종양 영양학 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for oncology nutrition. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global oncology nutrition market from 2025 to 2032.

Key Insights:

• Oncology Nutrition Market Size (2025E): USD 1.70 Billion
• Projected Market Value (2032F): USD 3.0 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 8.2%

Oncology Nutrition Market - Report Scope:

Oncology nutrition plays a crucial role in the supportive care of cancer patients, helping to manage symptoms, improve treatment outcomes, and enhance the quality of life. Specialized nutritional products are designed to address malnutrition, muscle wasting, and immune suppression associated with cancer therapies. The oncology nutrition market serves hospitals, cancer treatment centers, homecare settings, and specialty clinics, offering formulations tailored for specific cancer types and patient needs. Market growth is driven by the rising prevalence of cancer, increasing awareness of the benefits of clinical nutrition, and advancements in nutritional science, leading to innovative formulations that improve patient health and treatment tolerance.

Market Growth Drivers:

The global oncology nutrition market is propelled by several key factors, including the growing incidence of cancer worldwide, leading to a higher demand for nutritional support in oncology care. The increasing adoption of enteral and parenteral nutrition among cancer patients undergoing chemotherapy, radiation, and surgery further drives market expansion. Technological advancements in oncology nutrition, such as immunonutrition formulations and personalized dietary plans based on genetic profiling, are enhancing patient outcomes and driving industry growth. Additionally, government initiatives and support programs promoting nutritional interventions for cancer patients create a favorable market environment.

Market Restraints:

Despite promising growth prospects, the oncology nutrition market faces challenges related to stringent regulatory requirements, high product costs, and limited reimbursement coverage in certain regions. Strict guidelines governing the formulation and approval of medical nutrition products pose barriers for market entry, impacting innovation and commercialization. Additionally, a lack of awareness and accessibility to specialized oncology nutrition products in developing regions limits market penetration. The complexity of integrating nutrition into cancer treatment protocols and physician hesitancy toward prescribing clinical nutrition further act as restraints.

Market Opportunities:

The oncology nutrition market presents significant growth opportunities driven by ongoing research in nutritional oncology, the increasing focus on personalized medicine, and the expansion of home-based cancer care solutions. The integration of artificial intelligence (AI) and digital health technologies in nutritional planning enhances patient monitoring and dietary compliance. Additionally, partnerships between healthcare providers, nutrition companies, and research institutions foster product development and market expansion. Emerging markets, particularly in Asia-Pacific and Latin America, offer significant growth potential due to improving healthcare infrastructure and rising cancer awareness.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the oncology nutrition market globally?
• Which cancer types and patient groups are driving the adoption of oncology nutrition?
• How are technological advancements reshaping the competitive landscape of the oncology nutrition market?
• Who are the key players contributing to the oncology nutrition market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global oncology nutrition market?

Competitive Intelligence and Business Strategy:

Leading players in the global oncology nutrition market, including Nestle Health Science, Abbott Laboratories, and Danone S.A., focus on innovation, clinical research, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced oncology nutrition solutions, including immunonutrition products, high-protein formulas, and plant-based medical nutrition options. Collaborations with oncology centers, hospitals, and regulatory bodies facilitate market access and promote clinical adoption. Additionally, emphasis on patient education, digital health integration, and cost-effective nutritional solutions drives market expansion and enhances patient outcomes.

Key Companies Profiled:

• Nestle Health Science
• Abbott Laboratories
• Danone S.A.
• Fresenius Kabi AG
• Mead Johnson & Company, LLC
• B. Braun Melsungen AG
• Hormel Foods Corporation
• Meiji Holdings Co., Ltd.
• Baxter International Inc.
• Ajinomoto Co., Inc.

Oncology nutrition Market Research Segmentation

By Cancer Type:

• Head and Neck Cancers
• Stomach and Gastrointestinal Cancers
• Liver Cancer
• Pancreatic Cancer
• Esophageal Cancer
• Lung Cancer
• Breast Cancer
• Blood Cancer

By End-use:

• Hospitals & Clinics
• Home Care

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Oncology Nutrition Market Snapshot, 2025 - 2032
• 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Cancer Type Lifecycle Analysis
• 2.4. Oncology Nutrition Market: Value Chain
  • 2.4.1. List of Raw Material Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Applications
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Technology Landscape

3. Global Oncology Nutrition Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Mn) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2019 - 2023
  • 3.2.2. Current Market Size Forecast, 2025 - 2032
• 3.3. Global Oncology Nutrition Market Outlook: Cancer Type
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Cancer Type, 2019 - 2023
  • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2025 - 2032
    • 3.3.3.1. Head and Neck Cancers
    • 3.3.3.2. Stomach and Gastrointestinal Cancers
    • 3.3.3.3. Liver Cancer
    • 3.3.3.4. Pancreatic Cancer
    • 3.3.3.5. Esophageal Cancer
    • 3.3.3.6. Lung Cancer
    • 3.3.3.7. Breast Cancer
    • 3.3.3.8. Blood Cancer
    • 3.3.3.9. Other Cancers
• 3.4. Market Attractiveness Analysis: Cancer Type
• 3.5. Global Oncology Nutrition Market Outlook: End Use
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End Use, 2019 - 2023
  • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2025 - 2032
    • 3.5.3.1. Hospitals & Clinics
    • 3.5.3.2. Home Care
    • 3.5.3.3. Others
• 3.6. Market Attractiveness Analysis: End Use

4. Global Oncology Nutrition Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
• 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia & Pacific
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America Oncology Nutrition Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 5.3.1. By Country
  • 5.3.2. By Cancer Type
  • 5.3.3. By End Use
• 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2025 - 2032
  • 5.5.1. Head and Neck Cancers
  • 5.5.2. Stomach and Gastrointestinal Cancers
  • 5.5.3. Liver Cancer
  • 5.5.4. Pancreatic Cancer
  • 5.5.5. Esophageal Cancer
  • 5.5.6. Lung Cancer
  • 5.5.7. Breast Cancer
  • 5.5.8. Blood Cancer
  • 5.5.9. Other Cancers
• 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2025 - 2032
  • 5.6.1. Hospitals & Clinics
  • 5.6.2. Home Care
  • 5.6.3. Others
• 5.7. Market Attractiveness Analysis

6. Europe Oncology Nutrition Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 6.3.1. By Country
  • 6.3.2. By Cancer Type
  • 6.3.3. By End Use
• 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkey
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2025 - 2032
  • 6.5.1. Head and Neck Cancers
  • 6.5.2. Stomach and Gastrointestinal Cancers
  • 6.5.3. Liver Cancer
  • 6.5.4. Pancreatic Cancer
  • 6.5.5. Esophageal Cancer
  • 6.5.6. Lung Cancer
  • 6.5.7. Breast Cancer
  • 6.5.8. Blood Cancer
  • 6.5.9. Other Cancers
• 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2025 - 2032
  • 6.6.1. Hospitals & Clinics
  • 6.6.2. Home Care
  • 6.6.3. Others
• 6.7. Market Attractiveness Analysis

7. East Asia Oncology Nutrition Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 7.3.1. By Country
  • 7.3.2. By Cancer Type
  • 7.3.3. By End Use
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2025 - 2032
  • 7.5.1. Head and Neck Cancers
  • 7.5.2. Stomach and Gastrointestinal Cancers
  • 7.5.3. Liver Cancer
  • 7.5.4. Pancreatic Cancer
  • 7.5.5. Esophageal Cancer
  • 7.5.6. Lung Cancer
  • 7.5.7. Breast Cancer
  • 7.5.8. Blood Cancer
  • 7.5.9. Other Cancers
• 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2025 - 2032
  • 7.6.1. Hospitals & Clinics
  • 7.6.2. Home Care
  • 7.6.3. Others
• 7.7. Market Attractiveness Analysis

8. South Asia & Oceania Oncology Nutrition Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 8.3.1. By Country
  • 8.3.2. By Cancer Type
  • 8.3.3. By End Use
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2025 - 2032
  • 8.5.1. Head and Neck Cancers
  • 8.5.2. Stomach and Gastrointestinal Cancers
  • 8.5.3. Liver Cancer
  • 8.5.4. Pancreatic Cancer
  • 8.5.5. Esophageal Cancer
  • 8.5.6. Lung Cancer
  • 8.5.7. Breast Cancer
  • 8.5.8. Blood Cancer
  • 8.5.9. Other Cancers
• 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2025 - 2032
  • 8.6.1. Hospitals & Clinics
  • 8.6.2. Home Care
  • 8.6.3. Others
• 8.7. Market Attractiveness Analysis

9. Latin America Oncology Nutrition Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 9.3.1. By Country
  • 9.3.2. By Cancer Type
  • 9.3.3. By End Use
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2025 - 2032
  • 9.5.1. Head and Neck Cancers
  • 9.5.2. Stomach and Gastrointestinal Cancers
  • 9.5.3. Liver Cancer
  • 9.5.4. Pancreatic Cancer
  • 9.5.5. Esophageal Cancer
  • 9.5.6. Lung Cancer
  • 9.5.7. Breast Cancer
  • 9.5.8. Blood Cancer
  • 9.5.9. Other Cancers
• 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2025 - 2032
  • 9.6.1. Hospitals & Clinics
  • 9.6.2. Home Care
  • 9.6.3. Others
• 9.7. Market Attractiveness Analysis

10. Middle East & Africa Oncology Nutrition Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 10.3.1. By Country
  • 10.3.2. By Cancer Type
  • 10.3.3. By End Use
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2025 - 2032
  • 10.5.1. Head and Neck Cancers
  • 10.5.2. Stomach and Gastrointestinal Cancers
  • 10.5.3. Liver Cancer
  • 10.5.4. Pancreatic Cancer
  • 10.5.5. Esophageal Cancer
  • 10.5.6. Lung Cancer
  • 10.5.7. Breast Cancer
  • 10.5.8. Blood Cancer
  • 10.5.9. Other Cancers
• 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2025 - 2032
  • 10.6.1. Hospitals & Clinics
  • 10.6.2. Home Care
  • 10.6.3. Others
• 10.7. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2024
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Stomach and Gastrointestinal Cancers
  • 11.2.3. Apparent Product Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Aceto
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Product
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. B. Braun Melsungen AG
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Product
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. Baxter
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Product
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. Fresenius Kabi AG
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Product
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. Global Health Products, Inc.
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Product
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy
  • 11.3.6. Hormel Foods Corporation
    • 11.3.6.1. Overview
    • 11.3.6.2. Segments and Product
    • 11.3.6.3. Key Financials
    • 11.3.6.4. Market Developments
    • 11.3.6.5. Market Strategy
  • 11.3.7. Mead Johnson & Company, LLC
    • 11.3.7.1. Overview
    • 11.3.7.2. Segments and Product
    • 11.3.7.3. Key Financials
    • 11.3.7.4. Market Developments
    • 11.3.7.5. Market Strategy
  • 11.3.8. Meiji Holdings Co., Ltd
    • 11.3.8.1. Overview
    • 11.3.8.2. Segments and Product
    • 11.3.8.3. Key Financials
    • 11.3.8.4. Market Developments
    • 11.3.8.5. Market Strategy
  • 11.3.9. Nestle S.A.
    • 11.3.9.1. Overview
    • 11.3.9.2. Segments and Product
    • 11.3.9.3. Key Financials
    • 11.3.9.4. Market Developments
    • 11.3.9.5. Market Strategy
  • 11.3.10. BioSig Technologies, Inc.
    • 11.3.10.1. Overview
    • 11.3.10.2. Segments and Product
    • 11.3.10.3. Key Financials
    • 11.3.10.4. Market Developments
    • 11.3.10.5. Market Strategy
  • 11.3.11. Auris Health, Inc.
    • 11.3.11.1. Overview
    • 11.3.11.2. Segments and Product
    • 11.3.11.3. Key Financials
    • 11.3.11.4. Market Developments
    • 11.3.11.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations